These actions incorporate class-extensive security labeling alterations and new article-marketing specifications for all ER/LA opioid analgesics. FDA also responded to 2 citizen petitions pertaining to labeling of opioids. “I've it under Regulate. I know very well what I’m performing.” — Kathryn Galvan recalling the words and phrases of he